issue

Sep 27, 2013

Volume 9 Number 5

Editorial

A sense of “déjà vu”?
Serruys PW
10.4244/EIJV9I5A87
free

Clinical research

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention
Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y, Zhong S-L
10.4244/EIJV9I5A90
free
Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique
Nijhoff F, Agostoni P, Samim M, Ramjankhan F, Kluin J, Doevendans P, Stella P
10.4244/EIJV9I5A91
free
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S
10.4244/EIJV9I5A93
free
A new methodology for accurate 3-dimensional coronary artery reconstruction using routine intravascular ultrasound and angiographic data: implications for widespread assessment of endothelial shear stress in humans
Bourantas C, Papafaklis M, Athanasiou L, Kalatzis F, Naka K, Siogkas P, Takahashi S, Saito S, Fotiadis D, Feldman C, Stone P, Michalis L
10.4244/EIJV9I5A94
free
Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography
Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S
10.4244/EIJV9I5A96
free
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial
Waksman R, Serra A, Loh J, Malik F, Torguson R, Stahnke S, Von Strandmann R, Rodríguez A
10.4244/EIJV9I5A98
free
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
Unverdorben M, Kleber F-X, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Borger MA, Degenhardt R, Scheller B
10.4244/EIJV9I5A99
free
Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale
Freixa X, Ibrahim R, Chan J, Garceau P, Dore A, Marcotte F, Mercier L-A, Pierre-Mongeon F, Basmadjian A, Khairy P, Asgar A
10.4244/EIJV9I5A100
free

Special report

Emergency transseptal transcatheter mitral valve-in-valve implantation
Fassa A-A, Himbert D, Brochet E, Alkhoder S, Al-Attar N, Brun P-Y, Wolff M, Nataf P, Vahanian A
10.4244/EIJV9I5A101
free
MitraClip® via direct right atrial access in case of a missing inferior vena cava
Frerker C, Meincke F, Seibert H-P, Alessandrini H, Kreidel F, Caspary M, Busse C, Schäfer U, Kuck K
10.4244/EIJV9I5A102
free

Tools & Techniques

How should I treat?

How should I treat severe paravalvular leakage after TAVI?
Reinthaler M, Empen K, Busch M, Konemann R, Ince H, Felix S
10.4244/EIJV9I5A104
free

Image in cardiology


Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved